ENOB News and Press, Enochian Biosciences Inc. From 06/08/20

Thinly traded micro cap Enochian Biosciences (NASDAQ: ENOB ) rockets  292%  premarket on robust volume in reaction to its announcement that it has completed a meeting with the FDA during which there was "strong alignment" between its planned development strategy for ENOB-HV-01 an...

Company encouraged by strong alignment with views of FDA’s CBER regarding ENOB-HV-01 LOS ANGELES, June 08, 2020 (GLOBE NEWSWIRE) -- (NASDAQ: ENOB) - Enochian BioSciences, Inc., a company focused on gene-modified cellular and immune therapies in infectious diseases and cancer, tod...

MacroGenics Reports Interim Clinical Data for Multiple Drug Candidates MacroGenics (MGNX) reported preliminary clinical data from the Phase 1 dose escalation and expansion clinical trial of MGD013 and from the Phase 1 dose expansion study of MGC018. The former drug candidate is aimed at tr...

Gainers: SIFCO Industries (NYSEMKT: SIF ) +94% . More news on: SIFCO Industries, Inc., Creative Realities, Inc., United Natural Foods, Inc., Stocks on the move, , Read more ...

Thinly traded Enochian Biosciences ( ENOB +23.5% ) is up on a 6x surge in volume, albeit on turnover of only 297K shares, on the heels of presentations at the American Society of Gene and Cell Therapy Annual Meeting on gene-modified cell therapies that, it says, represent potential cures...

• First presentation of a novel approach to potentially cure HIV   -  An in vivo study demonstrated a 164 percent increase in engraftment of genetically modified cells Poster Presentation - http://www.enochianbio.com/wp-content/uploads/2020/05/Final-Poster-Syn...

Gainers:  Stemline Therapeutics (NASDAQ: STML ) +154% . More news on: Stemline Therapeutics, Inc., MicroVision, Inc., Contango Oil & Gas Company, Stocks on the move, , Read more ...

Stocks market indices have gained a large portion of their value back after having been down as much as 34% over the past month. The major market averages are now off their high less than 20%. The unpredictable massive rally in these benchmarks included record moves that will surely be studied i...

Three of three abstracts were accepted for presentation at the Annual Meeting of the American Society of Cell and Gene Therapy (ASCGT); The presentations advance the scientific foundation of Enochian’s broad and deep pipeline for potential cures for HIV and Hepatitis B Virus (HB...

FDA has granted Enochian an INTERACT meeting for its innovative approach to autologous stem cell transplantation as a potential cure for HIV. INTERACT is the first available FDA interaction and is a key step in the process towards an Investigational New Drug (IND) to study first-...